Vonjo shows promise in improving blood counts for myelofibrosis patients, enhancing quality of life by reducing anemia-related symptoms. Antibody-drug conjugates are increasingly used in metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results